SCOTUS to consider deference standard in patent appeals in case of MS drug
By EsqSocial Corporation 01/04/14
The U.S. Supreme Court on Monday accepted a case involving patents for the multiple sclerosis drug Copaxone. The issue in the case is how much deference should be given findings of fact by trial judges in patent infringement litigation, report the Wall Street Journal (sub. req.),…